QualityStocks Stock Newsletters Archives - Page 14 of 1818

ThursdayAug 30, 2012 9:18 am

International Stem Cell Corp. (ISCO) Reports Investor Conference Schedule for September

International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today told investors of the conferences it will be presenting at next month. Wall Street Analyst Forum Investor Conference Date: Friday, September 7, 2012 Time: 10:35 am ET Location: Omni Parker House - Boston, MA Rodman & Renshaw Annual Global Investment Conference Date: Monday, September 10, 2012 Time: 11:40 am ET Location: The Waldorf Astoria Hotel, New York, NY Investors interested in attending these conferences should contact the event organizers.…

ThursdayAug 30, 2012 8:28 am

AcelRx Pharmaceuticals, Inc. (ACRX) Receives U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms

AcelRx Pharmaceuticals announced that patents have been approved for “Bioadhesive Drug Formulations for Oral Transmucosal Delivery," and "Bioadhesive Drug Formulations for Oral Transmucosal Delivery." The issued patents will provide intellectual property protection for a bioadhesive tablet for oral transmucosal administration of sufentanil through January 2027. AcelRx exclusively owns both patents. "We have made significant progress this year in establishing our intellectual property portfolio, with five issued US patents now underpinning our novel NanoTab technology," said Richard King, AcelRx's President and CEO. "We look forward to building on this success through emphasis on the device aspects of our technology platforms as…

ThursdayAug 30, 2012 8:22 am

Stevia First Corp. (STVF) Licenses Fermentation-based Intellectual Property from Vineland Research and Innovation Centre

Stevia First is an early-stage agribusiness focused on the industrial scale production of the natural sweetener stevia, which is used as a zero-calorie alternative to sugar in foods and beverages. The California-based company today announced that it has entered into an exclusive and worldwide intellectual property license with the Vineland Research and Innovation Centre of Ontario, Canada, regarding compositions and methods for producing steviol and steviol glycosides through fermentation-based production methods. Stevia First also said it has inked a separate consulting agreement with Vineland to assist with further development of the underlying intellectual property. The production of stevia extract involves…

WednesdayAug 29, 2012 2:51 pm

Santa Fe Gold Corp. (SFEG) Raises $2.3M via S-3 Offerings with Strong Sales/Output, Ramps Up Flagship Gold and Silver Project

Santa Fe Gold, the domestic precious metals-focused mineral developer with four advanced properties in mining-friendly districts, the flagship of which started running ore in April this year at a cost of only $364 per gold equivalent ounce, was pleased to announce today that the company pulled in some $2.3M from S-3 shelf registration statement-related offerings, largely from existing stockholders. Combined with the money coming in from the sale of gold and silver, this great news about the success of the offerings puts SFEG in a prime position to capitalize on the expansion potential at their flagship Summit silver-gold project. Recent…

WednesdayAug 29, 2012 2:47 pm

Trovagene, Inc. (TROV) Receives Milestone Payment from Ipsogen S.A.

Trovagene is developing its patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell deaths that cross the kidney barrier and can be detected in urine. The company is leveraging its intellectual property through out-licensing agreements. The company today announced that it has received a milestone payment from Ipsogen S.A., a subsidiary of Qiagen N.V. (Nasdaq: QGEN). This payment comes from a co-exclusive license agreement to manufacture and sell diagnostic kits for the detection of nucleophosmin protein (NPM1) mutations in patients with acute myeloid leukemia (AML). The payment was triggered…

WednesdayAug 29, 2012 10:11 am

Axcelis Technologies, Inc. (ACLS) Announces High Volume Follow-On Order from Major Chipmaker

Axcelis Technologies, a leader in supplying innovative, high-productivity solutions for the semiconductor industry, has announced its receipt of a multiple system follow-on order for its Integra RS plasma dry strip system from one of the leading semiconductor manufacturers in the world. The systems, which began shipping this month, will be utilized in the production of 3x nm and below NAND Flash devices at leading-edge fabs in Asia and the United States. Axcelis is pleased to expand its installed base in working with this industry leader and supporting its evolving manufacturing needs. The Integra dry strip system has shown superior manufacturing…

WednesdayAug 29, 2012 9:05 am

China Botanic Pharmaceutical, Inc. (CBP) to be Granted New Invention Patent in China

China Botanic Pharmaceutical recently announced that the State Intellectual Property Office of the People’s Republic of China (SIPO) will be granting the company a new invention patent on its comprehensive method to enhance the medicinal value of Schisandra, a key component in its pharmaceutical products. The company expects to receive the patent certificate by October 2012. China Botanic filed Patent Application No: 201010119861.3 in February 2010, which was followed by a two-year comprehensive review conducted by the SIPO. Upon grant of the new patent, the company anticipates securing market exclusivity for a period of 20 years. Research in China suggests…

WednesdayAug 29, 2012 9:04 am

Novelos Therapeutics, Inc. (NVLT) Develops CLR1502 (GLOW2) for Tumor Marking and Imaging

Most cancer patients will have some type of surgery. In fact, in 2011, approximately 1.3 million cancer patients were diagnosed with solid tumors in the U.S. alone. The need for surgery makes it imperative that doctors have an effective way to mark the outline of tumors. However, the present state of medical technology is unable to do so. According to Dr. Sharon Weber, Professor and Chief of Surgical Oncology, Vice Chair of Academic Affairs for General Surgery, University of Wisconsin Department of Surgery, and Director of Surgical Oncology, Carbone Cancer Center, “Current imaging modalities are extremely limited in their ability…

TuesdayAug 28, 2012 4:26 pm

SaveDaily, Inc. (SAVY) to Supply Alliant Credit Union of Chicago with Tax-favorable Investing Platform

SaveDaily, provider of mutual fund investing platforms for financial institutions, today said that Alliant Credit Union of Chicago will use SaveDaily's investing platform to offer its members additional Health Savings Account (HAS) choices, complementary to the union’s existing suite of member savings options. The SaveDaily platform gives financial institutions the option to offer mutual fund investing to their members for one low flat monthly charge. Investors in mutual funds are also offered unlimited positions and unlimited transactions without transaction fees, generating continued cost savings. “Our members are looking for more ways to save and grow their money,” Alliant Vice President…

TuesdayAug 28, 2012 3:08 pm

Force Energy Corp. (FORC) Spammed Aggressively

We have observed an influx of emails spamming Force Energy. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net Let us hear your thoughts below:

Site Search

Company Search

Category: QualityStocks Stock Newsletters